NYSE · CBRE

CBRE GROUP, Inc.

$139.46 +$3.91 (+2.88%) 1D After hours

Key Metrics

$39.69B
Market cap
30.25×
P/E · TTM
$42.17B
Revenue · TTM
$1.31B
Net income
EPS · TTM $4.33
Dividend yield
Free cash flow $897.00M
Beta · 1Y 0.79
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 1
    From its Jan 29 high, the share price fell 27%.

    Peak close $171.61 on Jan 29; trough close $124.64 on Jun 1. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -27%
  • Feb 12
    The stock moved -8.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 12
  • Feb 11
    The stock moved -12.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$39.69B
Enterprise value$43.12B
Shares outstanding292.8M
52-wk range$121.69 – $174.27
Avg volume · 20D1.7M
Net cash −$3.43B
Book value / share$28.13
IndustryReal Estate
ExchangeNYSE
About CBRE GROUP, Inc.
IPO dateJun 10, 2004
Employees155000

CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E30.25
P/S0.94
P/FCF44.25
EV/EBITDA
EV/Sales1.02
Graham №$52.35

Profitability

Gross
Operating 4.3%
Net 3.1%
FCF 2.1%
ROE / ROIC 15.5% · 12.0%

Financial Health

Current ratio1.08
Quick ratio
Debt / equity0.60
Debt / EBITDA
Net cash −$3.43B
Working capital$981.00M

Cash Flow · TTM

Operating CF $1.28B
Capex −$383.00M
Free cash flow $897.00M
Buybacks $1.08B
Dividends paid
Shareholder yield 2.7%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

3.2
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$52.35 vs $139.46
Trades 2.7× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings